klinische studies

  • 1 op de 5 Europese klinische studies tegen kanker, loopt in België

    België is een Europese leider in het onderzoek naar vooruitstrevende kankerbehandelingen. Een vijfde (20 procent) van de nieuwe, hoogtechnologische kankergeneesmiddelen en therapieën in Europa worden in ons land ontwikkeld of getest. De specifieke expertise van België in oncologie is opvallend: bijna een derde (29 procent) van de aanvragen om een klinische studie te starten, zijn kankerstudies.

    Lees meer
  • pharma.be Forum: Clinical trials, an clear asset for Belgium

    On May 9th, 2017, pharma.be organized a conference (called Forum) to discuss the importance of clinical trials for Belgium, the changing legal framework and the importance of collaboration between all healthcare actors. Over 180 people attended the conference, including representatives from the government and authorities, from the pharma industry, healthcare professionals, academics, hospitals, sickness funds, and, patients associations.

    Lees meer
  • NIEUWE BROCHURE: "Belgium, a European leader in clinical trials"

    In Europe it is nearly impossible to find other countries with as many clinical trials running as in Belgium. With 507 new applications for clinical trials in 2016 and a total of 1,399 trials that year, Belgium is one of the leaders in Europe. Based on the number of inhabitants, Belgium is in 2nd place in Europe.

    Lees meer